04/29/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 4/29/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the LabGun™ COVID-19 RT-PCR Kit, which received an Emergency Use Authorization from the Food and Drug Administration on April 29, 2020. The LabGun™ COVID-19 RT-PCR Kit is authorized for use on respiratory specimens collected from individuals who are suspected of COVID-19 by their healthcare provider. (PDF)
.png)
No hay comentarios:
Publicar un comentario